Propionic Acid

Propionic Acid

SCHEMBL4176366

CCC(=O)O.O=c1[nH]c2ccc(NS(=O)(=O)c3ccccc3Cl)cc2c2cc[nH]c12

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 11/20 0.63
ALDH1A1 P00352 1/20 0.47
HIF1A Q16665 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HTR6 P50406 3/20 0.43
HTR1A P08908 2/20 0.43
HTR1B P28222 2/20 0.43
HTR2C P28335 2/20 0.43
HTR1F P30939 2/20 0.43
HTR1D P28221 1/20 0.43
HTR2A P28223 1/20 0.43
HTR7 P34969 1/20 0.43
LMNA P02545 1/20 0.42
SLC22A12 Q96S37 1/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4163310 0.90 BRD4 (0.49) BRD4HTR6
Propionic Acid SCHEMBL4158106 0.88 BRD4 (0.60) BRD4HTR6
Propionic Acid SCHEMBL4169897 0.86 BRD4 (0.59) BRD4HIF1AHTR6MAPT
Propionic Acid SCHEMBL4157723 0.85 BRD4 (0.62) BRD4ALDH1A1HIF1AKMT2AHTR6
Propionic Acid SCHEMBL4153857 0.84 HTR6 (0.47) BRD4ALDH1A1MEN1KMT2AHTR6
Propionic Acid SCHEMBL4159609 0.84 BRD4 (0.45) BRD4
Propionic Acid SCHEMBL4157756 0.83 BRD4 (0.63) BRD4ALDH1A1HIF1AMEN1KMT2A
Propionic Acid SCHEMBL4155591 0.83 BRD4 (0.50) BRD4ALDH1A1HIF1AMEN1KMT2A
Propionic Acid SCHEMBL4157617 0.83 BRD4 (0.64) BRD4ALDH1A1MEN1KMT2AKDM4E
Propionic Acid SCHEMBL4163285 0.82 PKM (0.54) BRD4LMNAPOLBMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 BRD4 545/4885ALDH1A1 3830/4885HIF1A 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.